Patent US5089387A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5089387A Expired / Lapsed US ⏱️ 0.0 years remaining

Dna probe diffraction assay and reagents

Assignee: Adeza Biomedical Corp
•
Filing: 1988-07-07
•
Granted: 1992-02-18
•
Expires: 2008-07-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The assay of the subject invention uses DNA sequences as probes in a nucleic acid hybridization diffraction assay, to detect specific DNA sequences in a sample. Diffraction assay methodologies are applied to determine the presence and amount of analyte. This invention involves a discovery in the areas of supporting surfaces for a biogrid or biograting which provide greatly reduced non-specific hybridization and binding. A preferred process of this invention involves manufacturing a biograting for use in a light diffraction assay, and comprises adhering a uniform layer of hybridizing reagent comprising a nucleotide sequence on a smooth, solid surface and exposing the surface to UV radiation through a shadow mask with a diffraction grating pattern of lines to selectively deactivate the hybridizing reagent, leaving a biological diffraction grating design of lines of active hybridizing reagent. The smooth, solid surface is preferably selected from the group consisting of polysilicon and single crystalline silicon surfaces. The diffraction hybridizing assay method of this invention for determining the presence or quantity of an analyte in an aqueous sample comprises contacting a nucleic acid sequence diffraction biogrid with the sample under proper circumstances and for a sufficient time to permit nucleic acid hybridization between a nucleic acid sequence probe and an analyte; separating the biogrid from the sample; illuminating the biogrid with light from a light source; and determining the light diffracted by the diffraction hybridization assay surface.

Inventors

  • 👤 Yuh-Geng Tsay
  • 👤 Emanuel Calenoff
  • 👤 Eric K. Gustafson
  • 👤 Rick Trebino
  • 👤 John Lee

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 10:35
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/17; G01N21/47; G01N21/4788; C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6825; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54366; G01N33/54373; G01N21/75; G01N2021/757

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 28 words
A biograting for use in a light diffraction assay comprising a smooth surface having on said surface, a biological diffraction grating design of lines of active hybridizing reagent.
Claim 2
Dependent Claim 28 words
A biograting for use in a light diffraction assay comprising a smooth surface having on said surface, a biological diffraction grating design of lines of active hybridizing reagent.
Claim 3
Dependent Claim 13 words
The biograting of claim 1 wherein the hybridizing reagent is a nucleotide sequence.
Claim 4
Dependent Claim 32 words
The biograting of claim 1 wherein the smooth surface is selected from the group consisting of single crystalline silicon, aluminum, epitaxial silicon coatings, silicon nitride coatings, silicon dioxide coatings, and polysilicon coatings.
Claim 5
Dependent Claim 22 words
The biograting of claim 3 wherein the smooth surface is selected from the group consisting of polysilicon and single crystalline silicon surfaces.
Claim 6
Dependent Claim 21 words
The biograting of claim 1 wherein the biological diffraction grating design of lines of active hybridizing reagent is substantially non-light disturbing.
Claim 7
Dependent Claim 22 words
The biograting of claim 1 wherein the biological diffraction grating design of lines becomes light-disturbing in the presence of hybridization with analyte.
Claim 8
Dependent Claim 55 words
A process for manufacturing the biograting of claim 1, comprising adhering a uniform layer of hybridizing reagent on a smooth, solid surface and exposing the surface to UV radiation through a shadow mask with diffraction grating lines to selectively deactivate the hybridizing reagent leaving a biological diffraction grating design of lines of active hybridizing reagent.
Claim 9
Dependent Claim 62 words
A process for manufacturing a biograting for use in a light diffraction assay, comprising: (a) adhering a uniform layer of hybridizing reagent on a smooth, solid surface; and (b) exposing the surface to UV radiation through a shadow mask with diffraction grating lines to selectively deactivate the hybridizing reagent to leave a biological diffraction grating design of lines of active hybridizing reagent.
Claim 10
Dependent Claim 62 words
A process for manufacturing a biograting for use in a light diffraction assay, comprising: (a) adhering a uniform layer of hybridizing reagent on a smooth, solid surface; and (b) exposing the surface to UV radiation through a shadow mask with diffraction grating lines to selectively deactivate the hybridizing reagent to leave a biological diffraction grating design of lines of active hybridizing reagent.
Claim 11
Dependent Claim 13 words
The biograting of claim 8 wherein the hybridizing reagent is a nucleotide sequence.
Claim 12
Dependent Claim 32 words
The biograting of claim 8 wherein the smooth surface is selected from the group consisting of single crystalline silicon, aluminum, epitaxial silicon coatings, silicon nitride coatings, silicon dioxide coatings, and polysilicon coatings.
Claim 13
Dependent Claim 22 words
The biograting of claim 10 wherein the smooth surface is selected from the group consisting of polysilicon and single crystalline silicon surfaces.
Claim 14
Dependent Claim 21 words
The biograting of claim 8 wherein the biological diffraction grating design of lines of active hybridizing reagent is substantially non-light disturbing.
Claim 15
Dependent Claim 22 words
The biograting of claim 8 wherein the biological diffraction grating design of lines becomes light-disturbing in the presence of hybridization with analyte.
Claim 16
Dependent Claim 55 words
A process for manufacturing the biograting of claim 8, comprising adhering a uniform layer of hybridizing reagent on a smooth, solid surface and exposing the surface to UV radiation through a shadow mask with diffraction grating lines to selectively deactivate the hybridizing reagent leaving a biological diffraction grating design of lines of active hybridizing reagent.
Claim 17
Dependent Claim 89 words
An assay method for determining the presence or quantity of an analyte nucleotide sequence in an aqueous sample comprising (a) contacting an assay surface with the sample for a time sufficient to permit binding of hybridizing reagent and analyte, the assay surface having on said surface, a light disturbing design of substantially non-light disturbing hybridizing reagent thereon, the hybridizing reagent being selected to hybridize selectively with the analyte; and (b) illuminating the assay surface with light from a light source, and determining the light diffracted by the assay surface.
Claim 18
Dependent Claim 89 words
An assay method for determining the presence or quantity of an analyte nucleotide sequence in an aqueous sample comprising (a) contacting an assay surface with the sample for a time sufficient to permit binding of hybridizing reagent and analyte, the assay surface having on said surface, a light disturbing design of substantially non-light disturbing hybridizing reagent thereon, the hybridizing reagent being selected to hybridize selectively with the analyte; and (b) illuminating the assay surface with light from a light source, and determining the light diffracted by the assay surface.
Claim 19
Dependent Claim 17 words
The assay method of claim 15 wherein the analyte nucleotide sequence is derived from a body tissue.
Claim 20
Dependent Claim 17 words
The assay method of claim 15 wherein the analyte nucleotide sequence is present in a body fluid.
Claim 21
Dependent Claim 25 words
The assay method of claim 17 wherein the analyte nucleotide sequence is present in urine, blood serum, blood plasma, milk, cerebrospihal fluid, mucus or sputum.
Claim 22
Dependent Claim 22 words
The assay method of claim 17 wherein the analyte nucleotide sequence is present in bacteria, viruses, fungi, algae, animal or plant cells.
Claim 23
Dependent Claim 29 words
The assay method of claim 15 wherein the analyte is a nucleotide sequence having origin in a fetal cell, adult cell, bacteria, virus, Mycoplasmatales, spore, algae, parasite, or yeast.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-02-17 1995-08-19 1996-02-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-02-17 1999-08-19 2000-02-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-02-17 2003-08-19 2004-02-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag